SCHEMBL22755000

SCHEMBL22755000

O=C(NC1CCCCC1)c1c[nH]c2c(Cl)c[nH]c(=O)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.48
▸ RAB9A P51151 4/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ ADORA2A P29274 1/20 0.45
▸ CA12 O43570 2/20 0.43
▸ CA1 P00915 2/20 0.43
▸ CA2 P00918 2/20 0.43
▸ CA4 P22748 2/20 0.43
▸ CA6 P23280 2/20 0.43
▸ CA5A P35218 2/20 0.43
▸ CA7 P43166 2/20 0.43
▸ CA9 Q16790 2/20 0.43
▸ CA13 Q8N1Q1 2/20 0.43
▸ CA14 Q9ULX7 2/20 0.43
▸ CA5B Q9Y2D0 2/20 0.43
▸ CA3 P07451 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ HTT P42858 2/20 0.43
▸ GAA P10253 2/20 0.43
▸ APOBEC3G Q9HC16 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22754845 0.85 NPC1 (0.50) NPC1RAB9ASMN1; SMN2ADORA2AALDH1A1
SCHEMBL22754927 0.85 KMT2A (0.47) NPC1RAB9ASMN1; SMN2ADORA2AALDH1A1
SCHEMBL22755113 0.83 ADORA2A (0.48) NPC1RAB9ASMN1; SMN2ADORA2AALDH1A1
SCHEMBL22754994 0.79 CD38 (0.46) EPHX2
SCHEMBL16610381 0.75 ALDH1A1 (0.48) NPC1RAB9ASMN1; SMN2ADORA2AALDH1A1
SCHEMBL22755311 0.71 MAPK14 (0.39) ADORA2AALDH1A1KMT2ABACE1MAPK14
SCHEMBL16610115 0.70 NPC1 (0.51) NPC1RAB9ASMN1; SMN2ADORA2AALDH1A1
SCHEMBL22755082 0.70 ADORA2A (0.38) NPC1RAB9AADORA2AALDH1A1KMT2A
SCHEMBL22755259 0.68 ALDH1A1 (0.49) NPC1RAB9ASMN1; SMN2ADORA2AALDH1A1
SCHEMBL3455501 0.67 RAB9A (0.72) NPC1RAB9ASMN1; SMN2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3747885-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2020-12-09 — — EP disclosed
Send feedback